Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20408137 | 0.96 | ACHE (0.42) | ALDH1A1CYP3A4CYP2C9CYP2C19TDP1 | |
| SCHEMBL5357367 | 0.95 | HSD17B1 (0.40) | ALDH1A1CYP3A4CYP2C9CYP2C19TDP1 | |
| SCHEMBL19301928 | 0.91 | ALDH1A1 (0.39) | ALDH1A1CYP3A4CYP2C9CYP2C19TDP1 | |
| SCHEMBL13017732 | 0.90 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19TDP1 | |
| SCHEMBL13721286 | 0.90 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19TDP1 | |
| SCHEMBL7169458 | 0.90 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19TDP1 | |
| SCHEMBL13721235 | 0.90 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19TDP1 | |
| SCHEMBL22812841 | 0.90 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19TDP1 | |
| SCHEMBL13721082 | 0.90 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19TDP1 | |
| SCHEMBL10039954 | 0.90 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2984079-B1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LTD (GB) | 2020-07-01 | — | — | EP | disclosed |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | POWER OLEDS LIMITED (GB) | 2019-10-08 | — | — | US | disclosed |
| US-20180323378-A9 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LIMITED (GB) | 2018-11-08 | — | — | US | disclosed |
| EP-3309804-A1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION AND OXIDE SEMICONDUCTOR ELECTRODE | Fujifilm Corporation (JP) | 2018-04-18 | — | — | EP | disclosed |
| EP-2984079-A2 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | Power Oleds Limited (GB) | 2016-02-17 | — | — | EP | disclosed |
| US-20160035983-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LTD (GB) | 2016-02-04 | — | — | US | disclosed |
| WO-2014167286-A2 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LIMITED (GB) | 2014-10-16 | — | — | WO | disclosed |
| US-20080241591-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND PHENYLENEDIAMINE DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2008-10-02 | — | — | US | disclosed |
| US-7399537-B2 | Organic electroluminescence device and phenylenediamine derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2008-07-15 | — | — | US | disclosed |
| US-20060082294-A1 | Organic electroluminescence device and phenylenediamine derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2006-04-20 | — | — | US | disclosed |
| EP-0906947-B1 | Indolocarbazole electroluminescent devices | XEROX CORP (US) | 2003-05-21 | — | — | EP | disclosed |
| US-6541129-B1 | Having a long life time that can decrease the driving voltage; using a phenylenediamine material having a small ionization potential and exhibiting a large hole mobility | IDEMITSU KOSAN CO., LTD. (JP) | 2003-04-01 | — | — | US | disclosed |
| EP-0906948-B1 | Electroluminescent devices | XEROX CORP (US) | 2003-02-12 | — | — | EP | disclosed |
| EP-1029909-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND PHENYLENEDIAMINE DERIVATIVE | Idemitsu Kosan Co., Ltd. (JP) | 2000-08-23 | — | — | EP | disclosed |
| US-5952115-A | Electroluminescent devices | XEROX CORPORATION (US) | 1999-09-14 | — | — | US | disclosed |
| US-5942340-A | CHARGE TRANSPORTING COMPONENT CONTAINING INDOLOCARBAZOLE COMPOUND; ENHANCED THERMAL AND OPERATIONAL STABILITY, DURABILITY | XEROX CORPORATION (US) | 1999-08-24 | — | — | US | disclosed |
| EP-0908787-A2 | Indolocarbazole Photoconductors | Xerox Corporation (US) | 1999-04-14 | — | — | EP | disclosed |
| EP-0906947-A1 | Indolocarbazole electroluminescent devices | XEROX CORPORATION (US) | 1999-04-07 | — | — | EP | disclosed |
| EP-0906948-A1 | Electroluminescent devices | Xerox Corporation (US) | 1999-04-07 | — | — | EP | disclosed |
| US-5843607-A | Indolocarbazole photoconductors | XEROX CORPORATION (US) | 1998-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180323378-A9 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | NAT1, SLCO2A1, SLCO2B1 | ALDH1A1 789/4885CYP3A4 384/4885CYP2C9 460/4885 |
| US-20080241591-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND PHENYLENEDIAMINE DERIVATIVE | MAL2, L1CAM, EPCAM | ALDH1A1 734/4885CYP3A4 710/4885CYP2C9 820/4885 |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | NAT1, SLCO2A1, SLCO2B1 | ALDH1A1 789/4885CYP3A4 384/4885CYP2C9 460/4885 |
| US-20160035983-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | NAT1, SLCO2A1, SLCO2B1 | ALDH1A1 789/4885CYP3A4 384/4885CYP2C9 460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.